Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.
Journal: Dermatology and therapy
Published: April 13, 2023
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
Journal: Rheumatology (Oxford, England)
Published: September 22, 2021
Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.
Journal: Journal of the American Academy of Dermatology
Published: May 01, 2020
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
Journal: Rheumatology (Oxford, England)
Published: January 08, 2020
Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.
Journal: Journal of the American Academy of Dermatology
Published: December 17, 2019
No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
Journal: Journal of the American Academy of Dermatology
Published: September 19, 2019
Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.
Journal: Dermatology and therapy
Published: August 30, 2019
Defining Pain That Does Not Interfere With Activities Among Rheumatoid Arthritis Patients.
Journal: Arthritis care & research
Published: June 19, 2019
Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat-to-Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology.
Journal: Arthritis care & research
Published: May 01, 2019
Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.
Journal: Journal of clinical medicine
Published: April 30, 2019
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: October 04, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026